Incorporating Health Equity in HTA Systems and Research: A Global Perspective and Future Outlook
Author(s)
Moderator: Riku Ota, MPH, Novo Nordisk A/S, København, 85, Denmark
Speakers: Ataru Igarashi, Ph.D., Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan; Melanie D. Whittington, PhD, MS, Tufts Medical Center (CEVR), Boston, MA, USA; Sreeram Ramagopalan, PhD, Health Analytics, Lane Clark & Peacock, London, LON, UK
Presentation Documents
Ota will open the session by describing the importance of accounting for equity within HTA from the industry perspective and then will invite panelists representing diverse geographical regions and professional backgrounds to share the current state of health equity research within HTA. Then, each speaker will describe how health equity is currently considered within HTA in their region based on their experience in their professional role (Dr Igarashi-academic, Dr Ramagopalan-regulatory, and Dr Whittington-value assessment). Each panelist will present an agenda for the next three to five years that will allow for the better incorporation of health equity considerations within HTA decision-making and research activities. The role of each stakeholder group (i.e., industry, academic, regulatory, value assessment) in promoting the consideration of health equity will be addressed, reflecting upon panelists’ diversified professional roles. Using the polling software, we will ask participants about the outlook of health equity at the beginning and the end of the workshop. Twenty minutes will be reserved for audience comments.
Conference/Value in Health Info
Code
217
Topic
Health Policy & Regulatory